TGA reviewing 751 submissions as industry outlines roadmap for reform

The Therapeutic Goods Administration (TGA) has begun analysing more than 750 submissions received during its consultation on medicinal cannabis regulations, in what is expected to signal the most significant reform of the framework since legalisation almost a decade ago.

In a coordinated response, Medicinal Cannabis Industry Australia (MCIA) and the Australian Medicinal Cannabis Association (AMCA) lodged a joint submission on behalf of their members, with both organisations together representing around 60% of the sector.